Andreas E Kremer1, Ruth Bolier2, Peter H Dixon3, Victoria Geenes3, Jenny Chambers3, Dagmar Tolenaars2, Carrie Ris-Stalpers4, Bernhard M Kaess5, Christian Rust6, Joris A van der Post4, Catherine Williamson3, Ulrich Beuers2, Ronald P J Oude Elferink7. 1. Tytgat Institute for Liver and Intestinal Research and Department of Hepatology & Gastroenterology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Department of Medicine I, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany. 2. Tytgat Institute for Liver and Intestinal Research and Department of Hepatology & Gastroenterology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. 3. Maternal and Fetal Disease Group, Division of Women's Health, Guy's Campus, King's College London, London, United Kingdom. 4. Women's and Children's Clinic, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. 5. Deutsches Herzzentrum, Technische Universität, Munich, Germany. 6. Department of Medicine II, Klinikum Grosshadern, University of Munich, Munich, Germany; Department of Internal Medicine I, Hospital Barmherzige Brüder Munich, Munich, Germany. 7. Tytgat Institute for Liver and Intestinal Research and Department of Hepatology & Gastroenterology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: r.p.oude-elferink@amc.uva.nl.
Abstract
BACKGROUND & AIMS: Intrahepatic cholestasis of pregnancy (ICP) is defined by pruritus, elevated total fasting serum bile salts (TBS) and transaminases, and an increased risk of adverse fetal outcome. An accurate diagnostic marker is needed. Increased serum autotaxin correlates with cholestasis-associated pruritus. We aimed at unraveling the diagnostic accuracy of autotaxin in ICP. METHODS: Serum samples and placental tissue were collected from 44 women with uncomplicated pregnancies and 105 with pruritus and/or elevated serum transaminases. Autotaxin serum levels were quantified enzymatically and by Western blotting, autotaxin gene expression by quantitative PCR. RESULTS: Serum autotaxin was increased in ICP (mean ± SD: 43.5 ± 18.2 nmol ml(-1)min(-1), n=55, p<0.0001) compared to other pruritic disorders of pregnancy (16.8 ± 6.7 nmol ml(-1)min(-1), n=33), pre-eclampsia complicated by HELLP-syndrome (16.8 ± 8.9 nmol ml(-1)min(-1), n=17), and pregnant controls (19.6 ± 5.7 nmol ml(-1)min(-1), n=44). Longitudinal analysis during pregnancy revealed a marked rise in serum autotaxin with onset of ICP-related pruritus. Serum autotaxin was increased in women taking oral contraceptives. Increased serum autotaxin during ICP was not associated with increased autotaxin mRNA in placenta. With a cut-off value of 27.0 nmol ml(-1)min(-1), autotaxin had an excellent sensitivity and specificity in distinguishing ICP from other pruritic disorders or pre-eclampsia/HELLP-syndrome. Serum autotaxin displayed no circadian rhythm and was not influenced by food intake. CONCLUSIONS: Increased serum autotaxin activity represents a highly sensitive, specific and robust diagnostic marker of ICP, distinguishing ICP from other pruritic disorders of pregnancy and pregnancy-related liver diseases. Pregnancy and oral contraception increase serum autotaxin to a much lesser extent than ICP.
BACKGROUND & AIMS:Intrahepatic cholestasis of pregnancy (ICP) is defined by pruritus, elevated total fasting serum bile salts (TBS) and transaminases, and an increased risk of adverse fetal outcome. An accurate diagnostic marker is needed. Increased serum autotaxin correlates with cholestasis-associated pruritus. We aimed at unraveling the diagnostic accuracy of autotaxin in ICP. METHODS: Serum samples and placental tissue were collected from 44 women with uncomplicated pregnancies and 105 with pruritus and/or elevated serum transaminases. Autotaxin serum levels were quantified enzymatically and by Western blotting, autotaxin gene expression by quantitative PCR. RESULTS: Serum autotaxin was increased in ICP (mean ± SD: 43.5 ± 18.2 nmol ml(-1)min(-1), n=55, p<0.0001) compared to other pruritic disorders of pregnancy (16.8 ± 6.7 nmol ml(-1)min(-1), n=33), pre-eclampsia complicated by HELLP-syndrome (16.8 ± 8.9 nmol ml(-1)min(-1), n=17), and pregnant controls (19.6 ± 5.7 nmol ml(-1)min(-1), n=44). Longitudinal analysis during pregnancy revealed a marked rise in serum autotaxin with onset of ICP-related pruritus. Serum autotaxin was increased in women taking oral contraceptives. Increased serum autotaxin during ICP was not associated with increased autotaxin mRNA in placenta. With a cut-off value of 27.0 nmol ml(-1)min(-1), autotaxin had an excellent sensitivity and specificity in distinguishing ICP from other pruritic disorders or pre-eclampsia/HELLP-syndrome. Serum autotaxin displayed no circadian rhythm and was not influenced by food intake. CONCLUSIONS: Increased serum autotaxin activity represents a highly sensitive, specific and robust diagnostic marker of ICP, distinguishing ICP from other pruritic disorders of pregnancy and pregnancy-related liver diseases. Pregnancy and oral contraception increase serum autotaxin to a much lesser extent than ICP.
Authors: Vinod S Hegade; Ruth Bolier; Ronald Pj Oude Elferink; Ulrich Beuers; Stuart Kendrick; David Ej Jones Journal: Frontline Gastroenterol Date: 2015-08-26
Authors: Shadi Abu-Hayyeh; Caroline Ovadia; TinaMarie Lieu; Dane D Jensen; Jenny Chambers; Peter H Dixon; Anita Lövgren-Sandblom; Ruth Bolier; Dagmar Tolenaars; Andreas E Kremer; Argyro Syngelaki; Muna Noori; David Williams; Jose J G Marin; Maria J Monte; Kypros H Nicolaides; Ulrich Beuers; Ronald Oude-Elferink; Paul T Seed; Lucy Chappell; Hanns-Ulrich Marschall; Nigel W Bunnett; Catherine Williamson Journal: Hepatology Date: 2015-12-28 Impact factor: 17.425
Authors: Willem-Jan Keune; Jens Hausmann; Ruth Bolier; Dagmar Tolenaars; Andreas Kremer; Tatjana Heidebrecht; Robbie P Joosten; Manjula Sunkara; Andrew J Morris; Elisa Matas-Rico; Wouter H Moolenaar; Ronald P Oude Elferink; Anastassis Perrakis Journal: Nat Commun Date: 2016-04-14 Impact factor: 14.919
Authors: Antonín Pařízek; Martin Hill; Michaela Dušková; Libor Vítek; Marta Velíková; Radmila Kancheva; Patrik Šimják; Michal Koucký; Zuzana Kokrdová; Karolína Adamcová; Andrej Černý; Zdeněk Hájek; Luboslav Stárka Journal: PLoS One Date: 2016-08-05 Impact factor: 3.240
Authors: Ewa Wunsch; Marcin Krawczyk; Malgorzata Milkiewicz; Jocelyn Trottier; Olivier Barbier; Markus F Neurath; Frank Lammert; Andreas E Kremer; Piotr Milkiewicz Journal: Sci Rep Date: 2016-08-10 Impact factor: 4.379